PHARMACY

NACDS supports California e-prescribing law to prevent opioid abuse
The National Association of Chain Drug Stores showed its support for the enactment of an electronic e-prescribing bill that will require healthcare practitioners to have the capability to transmit electronic data transmission prescriptions.
Pharmacy First brings credentialing, monitoring services to members
Pharmacy First members will get a robust credentialing, compliance and monitoring program through a partnership with Medversant Technologies.

Azova appoints new SVP of sales, operations

Azova announced that Ashton Maaraba, the former head of the product and partners team at eRx network, has been named its new senior vice president of sales and operations.
Sonig to head Lupin's generics, biosimilars business

Alok Sonig, the former CEO of developed markets at Dr. Reddy's, has been named the new CEO of Lupin's U.S. generics and global head generics R&D and biosimilars.
Senate passes NACDS-backed e-prescribing bill

The Senate has passed a package of measures focused on the opioid abuse epidemic, including the Every Prescription Conveyed Securely Act, S. 2460, which is backed by the National Association of Chain Drug Stores.
Camber Pharmaceuticals unveils generic Norvir for HIV

Camber has added ritonavir tablets, the generic of Abbvie's Norvir, to its portfolio.
Mylan launches generic Brevibloc injection in single-dose bags

Mylan is introducing the first generic of Baxter’s Brevibloc injection, which had a market value of approximately $126 million for the 12 months ending June 30, according to IQVIA.
Glenmark's generic Vagifem gets FDA approval

Glenmark received the FDA's green light for generic Vagifem, which had a market value of about $286.3 million, according to IQVIA.
Hikma Pharmaceuticals launches Adriamycin for injection

Hikma Pharmaceuticals has launched Adriamycin for injection, which is indicated for the treatment of such cancers as acute lymphoblastic leukemia, acute myeloblastic leukemia and metastatic breast cancer.
Synergy Medical continues rank among Canada’s top 500 companies

Synergy Medical came in at no. 397 on the Canadian Business and MacLean's annual list of fastest growing companies within Canada.